electroCore, Inc.
Overview
electroCore, Inc. develops bioelectronic medicines that use electrical stimulation to modulate neural activity for the treatment of inflammatory and neurological disorders. The company's proprietary technology platform delivers targeted neuromodulation through non-invasive and minimally invasive devices designed to restore normal nerve function and improve patient outcomes.
More in Neurotechnology
Latest industry news
Google and HHMI Janelia Publish the Complete Fruit Fly Brain Connectome — Built With AI
2026-09-28 · Research
St. Jude Wins FDA Approval for Neurostimulation Device Patients Can Upgrade Without Surgery
2026-09-28 · Policy
Flourish Emerges From Stealth With Bezos and Google Ventures Backing to Target Neuroscience
2026-09-27 · Funding
At-Home Neuromodulation Devices Are Moving Depression Treatment Out of the Clinic
2026-09-26 · Product
Company details
Category
🏢 Neurotechnology
Funding
Private
Listed
2026-07-10
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →